Delve into dermatology diseases with new approaches from conventional to complementary care.
Explore a broad spectrum of dermatological conditions and topics to enhance your practice.
Expert led instruction for every level of patient care.
Log in to see enrolled program content.
Gain practical insights and meet new colleagues.
Hover over a conference to view recordings.
The largest integrative dermatology community.

Case presentations featuring patients that have hidradenitis suppurativa and highlight our new HS CME series.

Case presentations featuring patients that have hidradenitis suppurativa and highlight our new HS CME series.

Description: This session will review the clinical presentation and severity grading of HS. The decision between topical and systemic therapies will be reviewed and the clinical evidence for TNF, JAK, and IL-17/23 inhibition will be discussed.

Join a global discussion on the emerging use of IL-17/23 inhibiting biologics, JAK inhibitors, and TEC inhibitors in clinical practice. Explore the evidence surrounding their safety and efficacy, referencing existing literature and expert insights. Stay informed about the latest advancements in these therapeutic approaches.

This live course panel of expert dermatologists will discuss multiple cases of HS focused on diagnosis and management.

This session will review the importance of shared decision making and how to most effectively involve the patient in diagnosis and treatment related discussions. The role of understanding the patient’s treatment and cultural perspectives will be explored along with how to incorporate discussions around pharmaceutical and nutrition based approaches.

This session will review how the prevalence and clinical presentation of HS may be altered in those with skin of color. The unique sequelae on the skin will be discussed along with the need to alter the therapeutic approach.

This session discusses what hidradenitis suppurativa is and the impact it has on patients. The pathophysiology of HS is reviewed along with other potential differential diagnoses. Engage in an interactive case scenario handout where you can test your knowledge on HS disease states and disease management.

Hidradenitis suppurativa is a heterogeneous disease. Every patient is different but for each patient, the disease may be different on a given day. Therefore, despite the existence of management guidelines, creating a holistic treatment plan is not trivial. In this session, the creation of a treatment plan for patients with hidradenitis suppurativa will be explored via a case-based discussion with added focus on a patient's point of view.

HS is a tough disease to manage. Drugs and lifestyle changes alone, are often not enough to achieve remission. Surgical management is often needed and simple office-based procedures can make a big difference in outcomes. However, many clinicians are intimidated. It is time to shake off the hesitation, roll up your scrubs, and get to work! in this session, simple office-based procedures will be reviewed.

The aim of this course is to educate practitioners on the best way to have efficient and effective patient encounters. This includes building rapport at the initial consult and setting patient expectations with regards to treatment responses, types of treatment that may be necessary, and long term goals. Emphasis will be placed on providing focused and critical education for patients regarding their disease. Approaches for management of acute flares will also be covered.

Hidradenitis Suppurativa (HS) is a multifactorial disease and is caused in part by changes in the skin microbiome. But what about the gut? And the impact of nutrition on HS? The health of the gut microbiome is increasingly being shown to be an important factor in health. This course will explore the evidence supporting the relationship between the gut-skin axis, nutrition, and HS.